Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
856.60
-7.65 (-0.89%)
< Home < Back

Zydus Cadila to set up an injectible facility at Vadodara

Date: 19-08-2013

Zydus Cadila is planning to set up an injectible facility at Vadodara at an investment of Rs 100 crore by 2015. It has already acquired the land for the same and it also aims to expand its hospital business across Gujarat in the next three years. The Ahmedabad-based company will target regulated markets like Brazil and Europe in the next turn.

Cadila Healthcare, the flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.